Covington Capital Management’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 894 |
|
|
2022
Q2 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 825 |
|
|
2022
Q1 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 865 |
|
|
2021
Q4 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 784 |
|
|
2021
Q3 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 707 |
|
|
2021
Q2 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 684 |
|
|
2021
Q1 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 669 |
|
|
2020
Q4 | $17K | Hold |
1,000
| – | – | ﹤0.01% | 606 |
|
|
2020
Q3 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 637 |
|
|
2020
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 693 |
|
|
2020
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 712 |
|
|
2019
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 745 |
|
|
2019
Q3 | $6K | Buy |
+1,000
| New | +$6K | ﹤0.01% | 717 |
|